Cargando…

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy

Recent advances in the understanding of immune function and the interactions with tumour cells have led to the development of various cancer immunotherapies and strategies for specific cancer types. However, despite some stunning successes with some malignancies such as melanomas and lung cancer, mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Macpherson, Anne M., Barry, Simon C., Ricciardelli, Carmela, Oehler, Martin K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564553/ https://www.ncbi.nlm.nih.gov/pubmed/32937961 http://dx.doi.org/10.3390/jcm9092967

Ejemplares similares

ABCA1 is associated with the development of acquired chemotherapy resistance and predicts poor ovarian cancer outcome
por: Wang, Wanqi, et al.
Publicado: (2021)

4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer
por: Lim, Shu Ly, et al.
Publicado: (2014)

Role of Versican, Hyaluronan and CD44 in Ovarian Cancer Metastasis
por: Ween, Miranda P., et al.
Publicado: (2011)

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery
por: Martin, Karina, et al.
Publicado: (2011)

Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism
por: Leung, Dilys, et al.
Publicado: (2022)

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance
por: Ricciardelli, Carmela, et al.
Publicado: (2017)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

Reduced Gonadotrophin Receptor Expression Is Associated with a More Aggressive Ovarian Cancer Phenotype
por: Cheung, Janelle, et al.
Publicado: (2020)

Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer
por: Ween, Miranda P., et al.
Publicado: (2012)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis
por: Lokman, Noor A., et al.
Publicado: (2013)

S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer
por: Noye, Tannith M., et al.
Publicado: (2018)

A Comprehensive Molecular and Clinical Analysis of the piRNA Pathway Genes in Ovarian Cancer
por: Lee, Eunice, et al.
Publicado: (2020)

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis
por: Lokman, Noor A., et al.
Publicado: (2012)

Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer
por: Lokman, Noor A., et al.
Publicado: (2019)

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
por: Ricciardelli, Carmela, et al.
Publicado: (2013)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
por: Khetan, Riya, et al.
Publicado: (2022)

Disabled-2: a protein up-regulated by high molecular weight hyaluronan has both tumor promoting and tumor suppressor roles in ovarian cancer
por: Price, Zoe K., et al.
Publicado: (2023)

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and Challenges
por: Pilla, Lorenzo, et al.
Publicado: (2018)

Ovarian cancer immunotherapy: opportunities, progresses and challenges
por: Liu, Bei, et al.
Publicado: (2010)

Hormone Receptors and Epithelial Ovarian Cancer: Recent Advances in Biology and Treatment Options
por: Borella, Fulvio, et al.
Publicado: (2023)

Reducing the Invasiveness of Low- and High-Grade Endometrial Cancers in Both Primary Human Cancer Biopsies and Cell Lines by the Inhibition of Aquaporin-1 Channels
por: Khan, Sidra, et al.
Publicado: (2023)

Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2013)

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
por: Szymanowski, Wojciech, et al.
Publicado: (2023)

Cancer immunotherapy: recent advances and challenges
por: Swami, Umang, et al.
Publicado: (2021)

Recent Advances and Challenges in Cancer Immunotherapy
por: Peterson, Chelsea, et al.
Publicado: (2022)

Disabled-2 (DAB2): A Key Regulator of Anti- and Pro-Tumorigenic Pathways
por: Price, Zoe K., et al.
Publicado: (2022)

Immune checkpoints, their control by immunotherapy and ovarian cancer
por: Bose, Chinmoy K.
Publicado: (2017)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
por: Rodriguez, Galaxia M., et al.
Publicado: (2018)

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer
por: Huang, Xu, et al.
Publicado: (2023)

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.
por: Friedlander, M. L., et al.
Publicado: (1985)

Update on the challenges and recent advances in cancer immunotherapy
por: Baronzio, Gianfranco, et al.
Publicado: (2013)

Recent Advances and Challenges in Uveal Melanoma Immunotherapy
por: Fu, Yihang, et al.
Publicado: (2022)

Advances and challenges of immunotherapies in NK/T cell lymphomas
por: He, Ling, et al.
Publicado: (2023)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kcc47hteh4neccbfvof3h8s05b